Cyclic Adenosine Monophosphates for Reducing the Formation of Adhesions
- Detailed Technology Description
- None
- *Abstract
-
This invention involves compositions and methods for reducing the formation of adhesions by the administration of cyclic adenosine monophosphates.Applications* Local application in the tissue field where adhesion formation or injury may occur, will occur or has occurred* Systemic administration before tissue injury, during tissue injury or after tissue injury. Advantages1. Safety: In contrast to adhesion barriers, the invention would not involve placing a foreign body in the surgical cavity. Present adhesion barriers can cause immunological reactions. Also, the cyclic adenosine monophosphates are naturally-occuring substances and therefore should be quite safe.2. Convenience: The cyclic adenosine monophosphates can be quickly and easily administered with a syringe.3. Can be used in minimally-invasive surgery: This is an extremely important point because adhesion barriers are not approved for this applicaiton and minimally-invasive surgery is the future of surgery.4. Pharmaceutical characteristics: The cyclic adenosine monophosphates are highly stable and highly soluble in aqueous solutions.5. Unlike present adhesion barriers, the invention should be effective even if blood is in the surgical field.6. It is likely that the invention will be more efficacious than existing adhesion barriers.7. It is likely that the invention would speed tissue healing.Provisional Patent Application filed
- *Principal Investigator
-
Name: Edwin Jackson, Professor of Pharmacology and Medicine
Department: Med-Pharmacology and Chemical Biology
- Country/Region
- USA
For more information, please click Here
